Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme

This study is currently recruiting participants.
Verified May 2012 by Penn State University
Sponsor:
Information provided by (Responsible Party):
Sonia Vaida, Penn State University
ClinicalTrials.gov Identifier:
NCT00836095
First received: February 2, 2009
Last updated: January 31, 2013
Last verified: May 2012

February 2, 2009
January 31, 2013
January 2009
January 2013   (final data collection date for primary outcome measure)
Primary variable outcomes are: insertion time and insertion success rate [ Time Frame: December 2009 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00836095 on ClinicalTrials.gov Archive Site
oxygenation, ventilation ,malposition frequency, fiberoptic view (of the final anatomic position), oropharyngeal leak pressure, ventilatory parameters, ease of gastric tube insertion and need for interventions to achieve an effective airway. [ Time Frame: December 2009 ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme
A Randomized Controlled Trial Comparing the ProSeal Laryngeal Mask Airway With the Laryngeal Mask Airway Supreme in Mechanically Ventilated Patients

Laryngeal mask airway is a widely used device in routine anesthesia for airway management during surgery. It consists of a tube with an inflatable cuff that is inserted into the mouth after induction of general anesthesia. The Proseal Laryngeal mask airway and the Laryngeal mask airway Supreme are two variants of the Laryngeal mask airway. The laryngeal mask airway Supreme is a newer version of the laryngeal mask airway.

The research is being done to compare two variants of the laryngeal mask airway: the Proseal laryngeal mask airway and the Laryngeal mask airway Supreme. This study will determine if the newer model, the Laryngeal mask airway Supreme, is easier to insert and is better positioned than the older model, the Proseal laryngeal mask airway. Both models are approved for use by the FDA, and are routinely used to assure the airway during general anesthesia.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Adverse Effect of Unspecified General Anesthetics
  • Device: Supreme Laryngeal mask airway
    Supreme Laryngeal mask airway is a new, single use laryngeal mask airway variant
  • Device: Proseal laryngeal mask airway
    Proseal is a multiple use, variant of the laryngeal mask airway
  • Supreme LMA

    Supreme Laryngeal mask airway is a new, single use laryngeal mask airway variant.

    The choice of the airway device will be randomized by opening a sealed envelope immediately before induction. Both airway devices will be blindly inserted by an experienced attending anesthesiologist.

    Interventions:
    • Device: Supreme Laryngeal mask airway
    • Device: Proseal laryngeal mask airway
  • Active Comparator: Proseal LMA

    Proseal is a multiple use, variant of the laryngeal mask airway.

    The choice of the airway device will be randomized by opening a sealed envelope immediately before induction. Both airway devices will be blindly inserted by an experienced attending anesthesiologist.

    Interventions:
    • Device: Supreme Laryngeal mask airway
    • Device: Proseal laryngeal mask airway
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
130
December 2013
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 - 75 years
  • ASA I and II
  • Mallampatti class: I and II
  • Thyromental distance > than 6.5 cm
  • Interincisor distance > than 3 cm
  • BMI < 35 Kg/m2
  • Patients scheduled to undergo anesthesia with an LMA for minor extraperitoneal surgical procedures in supine position

Exclusion Criteria:

  • Weight < 50 kg
  • BMI > 35 Kg/m2
  • Pregnant patients
  • Known or expected difficult airway
  • Patients with active, untreated and unresolved gastroesophageal reflux
  • Esophageal pathology, pulmonary pathology
  • Laparoscopic procedures
  • ENT procedures, gastrointestinal procedures, intraperitoneal surgical procedure
Both
18 Years to 75 Years
No
Contact: Sonia J Vaida, M.D. 717-531-0000 ext 8434 svaida@psu.edu
United States
 
NCT00836095
IRB 29920
Yes
Sonia Vaida, Penn State University
Penn State University
Not Provided
Principal Investigator: Sonia J Vaida, MD Penn State
Penn State University
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP